Black Bird Biotech, Inc. filed its 10-K on Mar 21, 2023 for the period ending Dec 31, 2022. In this report its auditor, Farmer, Fuqua & Huff, P.C. , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
Apr. 16 | Black Bird Biotech, Inc. Appoints Nelson Grist as New CEO | CI |
Apr. 16 | Black Bird Biotech, Inc. Appoints Nelson Grist as Its Future Member of Its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 298K | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- BBBT Stock
- News Black Bird Biotech, Inc.
- Black Bird Biotech, Inc. Auditor Raises 'Going Concern' Doubt